Back to the list
Congress: ECR25
Poster Number: C-22566
Type: Poster: EPOS Radiologist (educational)
Authorblock: L. M. B. Teixeira, A. C. V. R. Uski, C. Abud, M. H. Pedroso, M. Costa, F. Lewin, H. Leao Filho, V. DA SILVA GONÇALVES, M. Ferreira; São Paulo/BR
Disclosures:
Lhuanna Mária Barbosa Teixeira: Nothing to disclose
Ana Claudia Vincenzi Raduan Uski: Nothing to disclose
Carolina Abud: Nothing to disclose
Maria Helena Pedroso: Nothing to disclose
Marina Costa: Nothing to disclose
Fabio Lewin: Nothing to disclose
Hilton Leao Filho: Nothing to disclose
VIRGINIA DA SILVA GONÇALVES: Nothing to disclose
Marília Ferreira: Nothing to disclose
Keywords: Abdomen, Liver, Oncology, MR, MR-Diffusion/Perfusion, MR-Functional imaging, Education, Imaging sequences, Radiation therapy / Oncology, Cancer, Education and training, Neoplasia
References
  1. Liu N, Wu Y, Tao Y, Zheng J, Huang X, Yang L, Zhang X. Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics. Cancers (Basel). 2023 Nov 11;15(22):5373. doi: 10.3390/cancers15225373. PMID: 38001633; PMCID: PMC10670473.
  2. Kim DH, Choi SH. Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis. J Liver Cancer. 2024 Sep;24(2):192-205. doi: 10.17998/jlc.2024.04.05. Epub 2024 Apr 15. PMID: 38616543; PMCID: PMC11449575.
  3. Nguyen SA, Merrill CD, Burrowes DP, Medellin GA, Wilson SR. Hepatocellular Carcinoma in Evolution: Correlation with CEUS LI-RADS. Radiographics. 2022 Jul-Aug;42(4):1028-1042. doi: 10.1148/rg.210149. Epub 2022 Apr 29. PMID: 35486579.
  4. Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol (NY). 2018 Jan;43(1):149-157. doi: 10.1007/s00261-017-1196-2. PMID: 28580538.
  5. American College of Radiology (2018) CT/MRI LI-RADS v2108 core. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf?la=en.
  6. Park SH, Heo S, Kim B, Lee J, Choi HJ, Sung PS, Choi JI. Targetoid Primary Liver Malignancy in Chronic Liver Disease: Prediction of Postoperative Survival Using Preoperative MRI Findings and Clinical Factors. Korean J Radiol. 2023 Mar;24(3):190-203. doi: 10.3348/kjr.2022.0560. Epub 2023 Jan 19. PMID: 36788766; PMCID: PMC9971837.
  7. Huang R, Zheng C, Xu G, Chen X, Shen J, Mao S. A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors. J Hepatocell Carcinoma. 2024 Apr 26;11:775-786. doi: 10.2147/JHC.S448257. PMID: 38689802; PMCID: PMC11060173.
  8. Min JH, Lee MW, Park HS, Lee DH, Park HJ, Lee JE, Park SJ, Kim SS, Park SH, Ha SY, Hwang JA, Cha DI, Park B. LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy. AJR Am J Roentgenol. 2022 Sep;219(3):421-432. doi: 10.2214/AJR.22.27380. Epub 2022 Mar 23. PMID: 35319906.
  9. SIRICA AE, JONES GJ. Desmoplastic Stroma and Cholangiocarcinoma: Clinical Implications and Therapeutic Targeting. Hepatology. 2014 jun;59 (6): 2059-2429.
  10. Kim JH, Joo I, Lee JM. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Korean J Radiol. 2019 Jul;20(7):1019-1041. doi: 10.3348/kjr.2018.0636. PMID: 31270973; PMCID: PMC6609440.
  11. Loy LM, Low HM, Choi JY, Rhee H, Wong CF, Tan CH. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review. AJR Am J Roentgenol. 2022 Aug;219(2):212-223. doi: 10.2214/AJR.21.26982. Epub 2022 Feb 16. PMID: 35170359.
  12. Fowler KJ, Burgoyne A, Fraum TJ, Hosseini M, Ichikawa S, Kim S, Kitao A, Lee JM, Paradis V, Taouli B, Theise ND, Vilgrain V, Wang J, Sirlin CB, Chernyak V. Pathologic, Molecular, and Prognostic Radiologic Features of Hepatocellular Carcinoma. Radiographics. 2021 Oct;41(6):1611-1631. doi: 10.1148/rg.2021210009. PMID: 34597222.
  13. Tang A, Fowler KJ, Chernyak V, Chapman WC, Sirlin CB. LI-RADS and transplantation for hepatocellular carcinoma. Abdom Radiol (NY). 2018 Jan;43(1):193-202. doi: 10.1007/s00261-017-1210-8. PMID: 28612162.
  14. Shao S, Liang Y, Kuang S, Chen J, Shan Q, Yang H, Zhang Y, Wang B, J Fowler K, Wang J, B Sirlin C. Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection. Bosn J Basic Med Sci. 2020 Aug 3;20(3):401-410. doi: 10.17305/bjbms.2019.4576. PMID: 31999940; PMCID: PMC7416181.
  15. Mahmud N. Selection for Liver Transplantation: Indications and Evaluation. Curr Hepatol Rep. 2020;19(3):203-212. doi: 10.1007/s11901-020-00527-9. Epub 2020 Jun 19. PMID: 32837824; PMCID: PMC7302921.
  16. Alexander LF, Little MD, Sanyal R. Liver Transplantation Imaging. Textbook of Gastrointestinal Radiology. 4th ed. Philadelphia, PA: Elsevier Saunders. 2014: 1737-1755.
  17. Doyle DJ, Khalili K, Guindi M, Atri M. Imaging features of sclerosed hemangioma. AJR Am J Roentgenol. 2007 Jul;189(1):67-72. doi: 10.2214/AJR.06.1076. PMID: 17579154.
  18. Shin J, Lee S, Hwang JA, Lee JE, Chung YE, Choi JY, Park MS. MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis. Eur Radiol. 2022 May;32(5):3319-3326. doi: 10.1007/s00330-021-08382-y. Epub 2022 Jan 15. PMID: 35031839.
  19. Mahdi Z, Ettel MG, Gonzalez RS, Hart J, Alpert L, Fang J, Liu N, Hammer ST, Panarelli N, Cheng J, Greenson JK, Swanson PE, Westerhoff M. Metastases can occur in cirrhotic livers with patent portal veins. Diagn Pathol. 2021 Feb 27;16(1):18. doi: 10.1186/s13000-021-01076-5. PMID: 33639984; PMCID: PMC7913426.
GALLERY